Sectors · US

Health Care

Data as of 2026-10-06 · Linked from 94 pages
An overview for this page is not available in English yet. The figures below are updated daily.

At a glance 2026-10-06 basis

Constituents94
Avg. 1W-1.00%
Avg. 1M-0.46%
Avg. 3M+9.72%
Up over 1M39.4%
Simple averages of constituents; not an index.

Constituents by market cap

CompanyMarket capDay1W1M3MP/E
존슨 앤드 존슨 JNJ $609.5B +0.73% -4.78% -7.43% -3.27% 29.0
애브비 ABBV $469.6B +0.35% +1.29% +3.99% +5.52% 74.7
머크 MRK $344.3B +1.72% -4.92% -5.58% +12.66% 108.5
유나이티드헬스 그룹 UNH $339.8B -0.60% +0.37% -5.24% -11.58% 24.1
노바티스(ADR) NVS $267.9B -0.10% -3.38% -12.00% -9.27% 39.6
써모 피셔 사이언티픽 TMO $250.2B -2.98% -3.39% +6.97% +28.71% 35.9
아스트라제네카 AZN $242.8B +1.33% -3.41% -2.51% -16.20% 109.3
암젠 AMGN $217.9B -0.09% -4.97% -7.92% +9.41% 24.9
길리어드 사이언스 GILD $179.3B -0.28% -4.66% -4.48% +6.19% —
애보트 래브러토리스 ABT $173.2B -1.94% -2.76% -9.39% +3.13% 31.9
화이자 PFE $156.2B +0.33% -4.25% -3.34% +14.35% 36.1
다나허 DHR $155.5B -2.53% -4.64% +3.83% +13.02% 38.8
인튜이티브 서지컬 ISRG $143.6B -0.42% -1.80% +10.38% -2.49% 45.8
Bristol-Myers Squibb Co. BMY $120.1B +1.33% -5.20% -10.82% +3.56% 12.9
메드트로닉 MDT $112.5B -1.00% +0.00% -7.52% +6.19% 21.5
CVS 헬스 CVS $111.3B -0.67% -0.77% -10.66% -17.27% 22.8
스트라이커 SYK $109.4B -2.46% -0.20% -8.22% -14.88% 29.3
매케손 MCK $106.7B +0.68% +6.57% +1.51% +12.58% 23.2
엘리밴스 헬스 ELV $85.6B +1.41% +1.87% -1.82% -3.84% 17.2
모더나 MRNA $81.1B -7.75% -7.86% +28.79% +154.01% —
리제네론 파머슈티컬스 REGN $74.8B +1.69% -1.57% -10.75% +11.44% 17.3
The Cigna Group CI $71.7B +1.14% -0.32% -2.88% -5.30% 11.2
보스턴 사이언티픽 BSX $61.4B -0.50% -3.85% -11.74% -5.85% 16.7
Natera, Inc. Common Stock NTRA $61.4B -5.87% -3.35% +22.08% +46.01% —
Cencora, Inc. COR $60.1B +0.46% +2.85% -4.41% +2.20% 22.9
Cardinal Health, Inc. CAH $54.0B +0.14% +4.26% -5.56% -1.56% 31.5
Edwards Lifesciences Corp EW $50.3B -0.86% -1.82% -3.80% -7.65% 50.0
Becton, Dickinson and Co. BDX $49.2B -0.20% -0.92% -2.40% +19.75% 52.3
휴마나 HUM $48.5B +0.05% +4.50% +0.68% +2.01% 37.9
Agilent Technologies Inc. A $48.3B -1.14% -3.26% +12.24% +31.19% 33.5
테바 파머슈티컬 인더스트리스(ADR) TEVA $46.3B -1.34% -1.71% +7.62% +17.72% 65.4
Veeva Systems Inc. VEEV $45.9B +0.02% +1.77% +3.06% +50.66% 45.2
Illumina Inc ILMN $44.3B -6.86% +0.57% +25.35% +45.65% 53.8
아이큐비아 홀딩스 IQV $43.8B -2.30% -3.35% -2.91% +27.57% 31.9
Waters Corp WAT $43.2B -0.84% -1.54% +6.61% +18.55% 260.3
Idexx Laboratories Inc IDXX $41.5B -2.21% -3.38% -3.73% -7.25% 36.4
BeOne Medicines Ltd. American Depositary Shares ONC $40.9B +0.31% -0.68% +1.26% +20.17% 62.4
Biogen Inc. Common Stock BIIB $33.0B -0.31% -1.84% +0.93% +11.24% 39.6
DexCom, Inc. DXCM $32.8B -4.04% -3.75% -5.13% +12.60% 32.8
센틴 CNC $31.8B +0.48% +3.86% -3.62% -3.70% —
레즈메드 RMD $31.3B -0.97% -0.96% -3.35% +7.21% 20.6
Alcon Inc. Ordinary Shares ALC $31.1B -1.77% -3.44% -10.37% -5.06% 70.7
Mettler-Toledo International MTD $30.9B -0.56% -0.28% +13.96% +22.75% 34.1
ZOETIS INC. ZTS $29.5B -0.11% +1.47% -5.91% -5.02% 11.3
앨나일램 파머슈티컬스 ALNY $29.4B +1.84% -11.86% -15.85% -30.78% 36.4
West Pharmaceutical Services, Inc. WST $26.5B -1.09% -1.06% +9.61% +5.36% 46.9
Roivant Sciences Ltd. Common Shares ROIV $25.8B -0.70% -2.66% +1.72% -1.55% —
퀘스트 다이어그노스틱스 DGX $25.6B -1.65% -1.54% -3.69% +9.69% 24.2
Royalty Pharma plc Class A Ordinary Shares RPRX $25.2B -0.39% -3.06% -11.76% -3.31% 31.0
가단트 헬스 GH $25.1B -8.83% -3.96% +5.75% +9.30% —
랩코프 LH $25.0B +0.99% +0.94% -4.64% +12.23% 25.0
Incyte Genomics Inc INCY $23.1B -1.23% -8.50% -11.06% -3.86% 14.3
United Therapeutics Corp UTHR $23.0B +0.97% +12.49% +11.08% -2.29% 17.6
Insmed, Inc. INSM $22.7B +1.35% -8.99% -16.68% -9.70% —
Tenet Healthcare Corporation New THC $20.9B -0.39% +0.34% -2.48% +25.31% 9.3
STERIS plc STE $20.6B -1.15% -0.95% -7.10% -0.40% 25.6
비아트리스 VTRS $20.2B -0.45% -3.20% +3.91% +5.28% —
Revvity, Inc. RVTY $17.6B -2.58% +0.35% +17.72% +40.19% 73.9
Zimmer Biomet Holdings, Inc. ZBH $17.5B -2.06% -1.82% -8.56% +2.42% 21.6
Medpace Holdings, Inc. Common Stock MEDP $17.3B -2.84% -3.09% +1.96% +13.33% 35.2
Top 60 of 94 shown.

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.